Carboplatin dose in combination chemotherapy for testicular cancer
- 30 June 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (6), 691-695
- https://doi.org/10.1016/0277-5379(91)90167-c
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.Journal of Clinical Oncology, 1991
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- The Management of Advanced Testicular TeratomaBritish Journal of Urology, 1988
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985
- Phase I studies with carboplatin at the Royal Marsden HospitalCancer Treatment Reviews, 1985
- Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group studyCancer, 1984
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982